GHRP-2
A synthetic ghrelin-like peptide that strongly triggers growth hormone release. Used in Japan as a diagnostic test.
- Evidence
- Limited human research
- Half-life
- Short
- Sources
- 2 cited
Is GHRP-2 FDA-approved?
Not FDA-approved.
Is GHRP-2 banned in sport?
Banned in sport by the World Anti-Doping Agency (WADA).
Overview
GHRP-2 binds the ghrelin receptor and causes a strong growth hormone pulse. It also raises appetite and, to a lesser extent, cortisol and prolactin. In Japan, pralmorelin is used as a test for adult growth hormone deficiency.
How it works
It switches on the growth hormone secretagogue (ghrelin) receptor in the pituitary and hypothalamus.
How long does GHRP-2 stay in the body?
Short; not well established for repeated use.
What it's studied for
- Diagnosing growth hormone deficiency
- Growth hormone release in children and adults
Reported side effects
- Increased hunger
- Higher cortisol and prolactin
Related: Mod GRF 1-29, GHRP-6, CJC-1295, Hexarelin.
Sources
The studies and prescribing labels this page is written from.
- Pralmorelin (GHRP-2): drug profile. Drugs R D, 2004 PubMed
- Robust growth hormone responses to GH-releasing peptide 2 in adolescents. J Pediatr Endocrinol Metab, 2024 PubMed